Cholesterol and hematopoietic stem cells: Inflammatory mediators of atherosclerosis

Stem Cells Translational Medicine

Volumn 3, Issue 5, 2014, Pages 549-552

  Lang, Jennifer K ^a   Cimato, Thomas R ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CHOLESTEROL; GRANULOCYTE COLONY STIMULATING FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 17; INTERLEUKIN 23; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; NEUTROPHIL COUNT; NONHUMAN; STEM CELL MOBILIZATION;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION MEDIATORS; MICE; MONOCYTES; NEUTROPHILS;

EID: 84899673105     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0205     Document Type: Article

References (27)

1. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013;339:161-166.
2. Rana JS, Boekholdt SM, Ridker PM et al. Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: The EPIC-Norfolk Prospective Population Study. J Intern Med 2007;262:678-689.
3. Swirski FK, Libby P, Aikawa E et al. Ly-6Chi monocytes dominate hypercholesterolemiaassociated monocytosis and give rise to macrophages in atheromata. J Clin Invest 2007;117: 195-205.
4. Berg KE, Ljungcrantz I, Andersson L et al. Elevated CD1411CD16-monocytes predict cardiovascular events. Circ Cardiovasc Genet 2012;5:122-131.
5. Combadière C, Potteaux S, Rodero M et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogatesLy6C(hi)andLy6C(lo)monocytosisandalmost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008;117:1649-1657.
6. Drechsler M, Megens RTA, van Zandvoort M et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation 2010;122:1837-1845.
7. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count asapredictor ofmyocardial infarction. N Engl J Med 1974;290:1275-1278.
8. Giugliano G, Brevetti G, Lanero S et al. Leukocyte count in peripheral arterial disease: A simple, reliable, inexpensive approach to cardiovascular risk prediction. Atherosclerosis 2010;210:288-293.
9. Massberg S, Schaerli P, Knezevic-Maramica I et al. Immunosurveillance by hematopoietic progenitor cells through blood, lymph and peripheral tissues. Cell 2007;131:994-1008.
10. Robbins CS, Chudnovskiy A, Rauch PJ et al. Extramedullary hematopoiesis generates Ly-6C(high)monocytes that infiltrate atherosclerotic lesions. Circulation 2012;125: 364-374.
11. Dutta P, Courties G, Wei Y et al. Myocardial infarction accelerates atherosclerosis. Nature 2012;487:325-329.
12. Psaltis PJ, Harbuzariu A, Delacroix S et al. Identification of a monocyte-predisposed hierarchy of hematopoietic progenitor cells in the adventitia of postnatal murine aorta. Circulation 2012;125:592-603.
13. Gomes AL, Carvalho T, Serpa J et al. Hypercholesterolemia promotes bone marrow cell mobilization by perturbing the SDF-1: CXCR4 axis. Blood 2010;115:3886-3894.
14. Feng Y, Schouteden S, Geenens R et al. Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density andlow-density lipoproteins inmice. PLoS One 2012;7:e47286.
15. Yvan-Charvet L, Ranalletta M, Wang N et al. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J Clin Invest 2007;117:3900-3908.
16. Yvan-Charvet L, Pagler T, Gautier EL et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010;328:1689-1693.
17. Westerterp M, Gourion-Arsiquaud S, Murphy AJ et al. Regulation of hematopoietic stem and progenitor cell mobilization by cholesterol efflux pathways. Cell Stem Cell 2012;11: 195-206.
18. Stark MA, Huo Y, Burcin TL et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005; 22:285-294.
19. Mayani H, Alvarado-Moreno JA, Flores-Guzmán P. Biology of human hematopoietic stem and progenitor cells present in circulation. Arch Med Res 2003;34:476-488.
20. Duda DG, Cohen KS, Scadden DT et al. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007;2:805-810.
21. Mund JA, Estes ML, Yoder MC et al. Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol 2012;32:1045-1053.
22. Cohen KS, Cheng S, Larson MG et al. Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood 2013;121:e50-e56.
23. Massa M, Rosti V, Ferrario M et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105: 199-206.
24. Case J, Mead LE, BesslerWKet al. Human CD341AC1331VEGFR-21 cells are not endothelial progenitor cells but distinct, primitivehematopoietic progenitors. Exp Hematol 2007;35: 1109-1118.
25. Cimato TR, Palka BA, Lang JK et al. LDL cholesterol modulates human CD341 HSPCs through effects on proliferation and the IL-17 G-CSF axis. PLoS One 2013;8:e73861.
26. Robertson A-KL, Hansson GK. T cells in atherogenesis: For better or for worse?. Arterioscler Thromb Vasc Biol 2006;26: 2421-2432.
27. Ma Y, Yuan X, Deng L et al. Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling. PLoS One 2013;8:e72804.